C07K 16/246
Il-2
Official title: {il-2}
C07K16/246 (Il-2) appears on 96 US grants and 202 published applications in this corpus.
Search patents in C07K- Granted patents
- 96
- Published applications
- 202
- Assignees
- 106
- Inventors
- 434
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 2 |
| 2003 | 1 | 2 |
| 2004 | 1 | 3 |
| 2005 | 1 | 1 |
| 2006 | 1 | 2 |
| 2007 | 1 | 4 |
| 2008 | 0 | 7 |
| 2009 | 0 | 1 |
| 2010 | 4 | 7 |
| 2011 | 1 | 3 |
| 2012 | 0 | 0 |
| 2013 | 2 | 4 |
| 2014 | 4 | 3 |
| 2015 | 2 | 4 |
| 2016 | 7 | 8 |
| 2017 | 3 | 8 |
| 2018 | 3 | 10 |
| 2019 | 5 | 10 |
| 2020 | 8 | 12 |
| 2021 | 5 | 11 |
| 2022 | 7 | 15 |
| 2023 | 7 | 19 |
| 2024 | 6 | 27 |
| 2025 | 10 | 21 |
| 2026 | 7 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Composition for cancer diagnosis18 Aug 2026US 12,710,425 B2Acurasysbio Co., Ltd.
- CD25-biased anti-IL-2 antibody28 Jul 2026US 12,692,306 B2UniversitäT ZüRich
- Cytokine-based therapies and methods30 Jun 2026US 12,668,627 B2Reverb Therapeutics, Inc.
- Masked IL-2 cytokines and methods of use thereof23 Jun 2026US 12,662,520 B2Xilio Development, Inc.
- Ligand-binding fusion proteins16 Jun 2026US 12,655,220 B2Chugai Seiyaku Kabushiki Kaisha
- Anti-il-2 antibody combinations and methods of use thereof17 Sep 2026US 2026/0274942 A1Aulos Bioscience, Inc.
- Novel cytokine-based therapies and methods17 Sep 2026US 2026/0274943 A1Reverb Therapeutics, Inc.
- Method for selectively inducing antigen-specific inductive regulatory t cells6 Aug 2026US 2026/0224622 A1Junten Bio Co., Ltd.
- Affinity and functional based screening of t cell receptor repertoire using three-dimensional shaped particles30 Jul 2026US 2026/0218282 A1The Regents of the University of California
- Anti-il-2 antibody combinations and methods of use thereof23 Jul 2026US 2026/0207741 A1Aulos Bioscience, Inc.
Most cited
By later US patents
- Methods for the production of proteins with a desired function384US 5,627,052 AB.R. Centre Limited · 1997
- Hybridoma antibody which inhibits interleukin 2 activity114US 4,411,993 A1983
- Inhibitor which is deactivatable by a reagent produced by a target cell91US 8,809,504 B22014
- Engineered heterodimeric protein domains58US 8,871,912 B2Merck Patent GmbH · 2014
- Engineered heterodimeric protein domains47US 9,505,848 B2Merck Patent GmbH · 2016